BioSpace4h
Altimmune To Test Investigational GLP-1–Based Obesity Drug for Alcohol Use Disorder
The Maryland-based biopharma joins Eli Lilly and Novo Nordisk in trialing a GLP-1 agonist for alcohol- and liver-related ...
Labiotech.eu4h
Can GLP-1 agonists help treat addiction?
As the potential of GLP-1 agonists for addiction gains traction, big pharma is also starting to take notice, namely the two ...
Endpoints News7d
No­vo Nordisk looks in­to start­ing GLP-1 drug tri­als for ad­dic­tion
Novo Nordisk considers exploring GLP-1 drugs like semaglutide for addiction treatment, following Eli Lilly's interest.
The Lancet8d
GLP-1 receptor agonists: even for kidney transplant recipients with pre-existing diabetes?
GLP-1 receptor agonists were initially approved for glycaemic control in type 2 diabetes and, subsequently, for bodyweight loss in obesity. Following large-scale trials demonstrating that some GLP-1 ...
Yahoo9d
More yogurt and nuts, less alcohol and snack foods: How GLP-1 medications like Ozempic are influencing people’s food spending habits
Research shows that people on GLP-1 medications are ditching processed foods and buying more nutrient-dense ones like fresh produce, beans and yogurt. (Photo illustrations: Yahoo News; photos ...
ConsumerAffairs10d
GLP-1 insurance coverage worsened at start of 2025, report says
Health insurance coverage for GLP-1 drugs isn't getting better despite surging demand from Americans looking to lose weight or treat Type 2 diabetes. The percentage of patients with no insurance ...
Yahoo Finance17d
resbiotic Unveils resM™ GLP-1 Postbiotic--A Groundbreaking Innovation in Gut & Metabolic Health
Feb. 25, 2025 /PRNewswire/ -- resbiotic (res), a leading physician-developed supplement brand, announced today the launch of their latest product innovation, resM™ GLP-1 Postbiotic. resM™ is a ...